Form 4: Teladoc Health Executive Arnnon Geshuri Executes Stock Option and Sells Shares

Teladoc Health's Chief People Officer, Arnnon Geshuri, exercised stock options and sold shares on March 25, 2024, according to a recent SEC filing.

Summary

• On March 25, 2024, Arnnon Geshuri, the Chief People Officer of Teladoc Health, Inc. [TDOC], exercised stock options to acquire 7,500 shares of common stock at a price of $2.73 per share.
• Simultaneously, Geshuri sold 7,500 shares of Teladoc Health common stock at a price of $15.06 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2023.
• Following these transactions, Geshuri directly owns 38,470 shares of Teladoc Health common stock and holds options for 220,278 shares.
• The stock options vest over time, with one-fourth vesting on December 4, 2018, and the remaining vesting monthly at a rate of 1/48.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine stock transactions by an executive under a pre-existing trading plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. These transactions are closely monitored by investors as they can provide insights into an executive's perspective on the company's future performance. Rule 10b5-1 plans are often used to avoid accusations of insider trading, as they are established in advance and operate according to a predetermined schedule.

Comparison to Industry Standards

• Executive compensation packages, including stock options, are standard practice across the healthcare technology industry.
• Companies like Amwell and Cerner (now Oracle Health) also utilize stock options as part of their executive compensation.
• The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance and retention.

Key Dates